Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Internal Medicine Journal
|
June 22, 2023
An extraordinary response to dual immune checkpoint inhibitor and vascular endothelial growth factor inhibition in a patient with hepatocellular carcinoma and follicular lymphoma
Zhen H Hong, Marcus Dickey, Philip Wong, et al.
Seminars in Oncology
|
July 19, 2020
COVID-19 and the cancer care workforce: From doctors to ancillary staff
Harry Gasper, Elizabeth Ahern, Natasha Roberts, et al.
Seminars in Oncology
|
February 16, 2023
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations
Natasha A Roberts, Elizabeth Ahern, Anita Pelecanos, et al.
JAMA Oncology
|
February 23, 2018
Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers: A Systematic Review and Meta-analysis
Georgia Ritchie, Harry Gasper, Johnathan Man, et al.
Expert Review of Molecular Diagnostics
|
March 9, 2021
Spatial profiling technologies and applications for brain cancers
Priyakshi Kalita-de Croft, Habib Sadeghi Rad, Harry Gasper, et al.
BMJ Open
|
May 7, 2021
Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia
Harry Gasper, Elizabeth Ahern, Natasha Roberts, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 30, 2020
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
Connor O'Leary, Harry Gasper, Katherine B Sahin, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 5, 2021
Resilience and ongoing quality care for cancer clinical trials during COVID-19: Experience from a tertiary hospital in Australia
Amy Ives, Tricia Pusztai, Jacqui Keller, et al.
Plos One
|
August 26, 2024
From many voices, one question: Community co-design of a population-based qualitative cancer research study
Susannah K Ayre, Elizabeth A Johnston, Xanthia E Bourdaniotis, et al.
The Lancet Regional Health. Western Pacific
|
February 6, 2026
Measuring cancer equity globally: harmonising international rural-urban classifications for exploring cancer outcomes
Charlene Wright, Sharina Riva, Megan Crichton, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Internal Medicine Journal
|
June 22, 2023
An extraordinary response to dual immune checkpoint inhibitor and vascular endothelial growth factor inhibition in a patient with hepatocellular carcinoma and follicular lymphoma
Zhen H Hong, Marcus Dickey, Philip Wong, et al.
Seminars in Oncology
|
July 19, 2020
COVID-19 and the cancer care workforce: From doctors to ancillary staff
Harry Gasper, Elizabeth Ahern, Natasha Roberts, et al.
Seminars in Oncology
|
February 16, 2023
From doctors to ancillary staff: Regional and metropolitan cancer workforce perceptions and distress resulting from COVID-19 pandemic adaptations
Natasha A Roberts, Elizabeth Ahern, Anita Pelecanos, et al.
JAMA Oncology
|
February 23, 2018
Defining the Most Appropriate Primary End Point in Phase 2 Trials of Immune Checkpoint Inhibitors for Advanced Solid Cancers: A Systematic Review and Meta-analysis
Georgia Ritchie, Harry Gasper, Johnathan Man, et al.
Expert Review of Molecular Diagnostics
|
March 9, 2021
Spatial profiling technologies and applications for brain cancers
Priyakshi Kalita-de Croft, Habib Sadeghi Rad, Harry Gasper, et al.
BMJ Open
|
May 7, 2021
Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia
Harry Gasper, Elizabeth Ahern, Natasha Roberts, et al.
Pharmaceuticals (Basel, Switzerland)
|
September 30, 2020
Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
Connor O'Leary, Harry Gasper, Katherine B Sahin, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 5, 2021
Resilience and ongoing quality care for cancer clinical trials during COVID-19: Experience from a tertiary hospital in Australia
Amy Ives, Tricia Pusztai, Jacqui Keller, et al.
Plos One
|
August 26, 2024
From many voices, one question: Community co-design of a population-based qualitative cancer research study
Susannah K Ayre, Elizabeth A Johnston, Xanthia E Bourdaniotis, et al.
The Lancet Regional Health. Western Pacific
|
February 6, 2026
Measuring cancer equity globally: harmonising international rural-urban classifications for exploring cancer outcomes
Charlene Wright, Sharina Riva, Megan Crichton, et al.
Page
of 2